MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-24-2025
NovoCure Limited Accounts Receivables 2011-2025 | NVCR
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables NovoCure Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 74.2 M | 61.2 M | 86.3 M | 93.6 M | 96.7 M | 58.9 M | 36.5 M | 29.6 M | 6.34 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 96.7 M | 6.34 M | 60.4 M |
Quarterly Accounts Receivables NovoCure Limited
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89.9 M | 84.5 M | 74.2 M | 67.1 M | 64.7 M | 65.1 M | 61.2 M | 65.1 M | 71 M | 74.8 M | 86.3 M | 87.6 M | - | 101 M | 93.6 M | 94.1 M | 90.4 M | 92.5 M | 96.7 M | 96.7 M | 96.7 M | 96.7 M | 58.9 M | 58.9 M | 58.9 M | 58.9 M | 36.5 M | 36.5 M | 36.5 M | 36.5 M | 29.6 M | 29.6 M | 29.6 M | 29.6 M | 6.34 M | 6.34 M | 6.34 M | 6.34 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 101 M | 6.34 M | 61.5 M |
Accounts Receivables of other stocks in the Health care industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cigna Corporation
CI
|
24.2 B | $ 276.37 | 0.62 % | $ 75.7 B |  USA |
 |
Humana
HUM
|
2.7 B | $ 273.95 | 2.12 % | $ 33 B | USA |
 |
CVS Health Corporation
CVS
|
36.5 B | $ 79.55 | 0.15 % | $ 100 B | USA |
 |
Molina Healthcare
MOH
|
3.3 B | $ 166.33 | -1.28 % | $ 9.55 B | USA |
 |
UnitedHealth Group Inc.
UNH
|
22.4 B | $ 340.29 | -0.45 % | $ 313 B | USA |